Related references
Note: Only part of the references are listed.Treatment Options for HIV-Associated Central Fat Accumulation
Joseph Cofrancesco et al.
AIDS PATIENT CARE AND STDS (2009)
GH/GHRH axis in HIV lipodystrophy
Takara L. Stanley et al.
PITUITARY (2009)
Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation
Julian Falutz et al.
AIDS (2008)
Metabolic effects of a growth hormone-releasing factor in patients with HIV
Julian Falutz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The role of adipokines in relation to HIV lipodystrophy
Laura L. Sweeney et al.
AIDS (2007)
Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature
JM Lee et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2006)
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy
D. A. Wohl et al.
CLINICAL INFECTIOUS DISEASES (2006)
A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation
J Falutz et al.
AIDS (2005)
Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy
P Koutkia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals
R Power et al.
SEXUALLY TRANSMITTED INFECTIONS (2003)
Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients
M Oette et al.
AIDS PATIENT CARE AND STDS (2002)
Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy
P Rietschel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Share Paper
